BONATI, Antonio
BONATI, Antonio
Dipartimento di Medicina e Chirurgia
A micro-mechanically motivated model for the strength of heat-treated glass
2018-01-01 Bonati, Antonio; Occhiuzzi, Antonio; Pisano, Gabriele; Royer-Carfagni, Gianni
Acenaphthenequinone thiosemicarbazone and its transition metal complexes: synthesis, structure, and biological activity.
1997-01-01 M. C., Rodriguez Argüelles; M., Belicchi Ferrari; G., Gasparri Fava; C., Pelizzi; Pelosi, Giorgio; Albertini, Roberto; Bonati, Antonio; P. P., Dall'Aglio; Lunghi, Paolo; S., Pinelli
Arsenic Trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells
2005-01-01 Lunghi, P.; Tabilio, A.; LO COCO, F.; Pelicci, P. G.; Bonati, Antonio
Arsenic Trioxide in hematological malignancies: the new discovery of an ancient drug.
2006-01-01 Bonati, Antonio; Rizzoli, V; Lunghi, P.
Aurora and IKK kinases cooperatively interact to protect multiple myeloma cells from Apo2L/TRAIL
2013-01-01 Mazzera, L; Lombardi, G; Abeltino, M; Ricca, M; Donofrio, Gaetano; Giuliani, Nicola; Cantoni, Anna Maria; Corradi, Attilio; Bonati, Antonio; Lunghi, Paolo
BCL2 oncogene protein expression in human hematopoietic precursors during fetal life.
1996-01-01 Bonati, Antonio; Albertini, Roberto; D., Garau; Pinelli, Silvana; Lunghi, Paolo; C., Almici; C., Carlo Stella; Rizzoli, Vittorio; P., Dall'Aglio
Biochemical, Immunological, and Molecular Markers of Hemopoietic Precursor Cells.
1991-01-01 Bonati, Antonio
Calibration of the Statistical-Interference Factors for the Design of Tempered Structural Glass
2022-01-01 Pisano, Gabriele; Bonati, Antonio; ROYER CARFAGNI, Gianni
Combined treatment with the MEK inhibitor PD0325901 and Arsenic Trioxide has potent anti-tumor activity in vivo against human multiple myeloma xenograft model.
2008-01-01 Lunghi, P; Mazzera, L; Lombardi, G; Ricca, M; Corradi, Attilio; Cantoni, Anna Maria; Giuliani, Nicola; Salvatore, L; Riccioni, R; Costanzo, A; Testa, U; Levrero, M; Rizzoli, Vittorio; Bonati, Antonio
Combined treatment with the MEK inhibitor PD0325901 and Arsenic Trioxide has potent antitumor activity in NOD-SCID mice bearing advanced tumors of human multiple myeloma.
2009-01-01 Lunghi, P; Mazzera, L; Lombardi, G; Ricca, M; Corradi, Attilio; Cantoni, Anna Maria; Giuliani, Nicola; Salvatore, L; Riccioni, R; Costanzo, A; Testa, U; Levrero, M; Rizzoli, V; Bonati, Antonio
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia
2008-01-01 Steelman, Ls; Abrams, Sl; Whelan, J; Bertrand, Fe; Ludwig, De; Bäsecke, J; Libra, M; Stivala, F; Milella, M; Tafuri, A; Lunghi, P; Bonati, Antonio; Martelli, Am; Mccubrey, Ja
Detection of the common acute lymphoblastic leukaemia antigen (CALLA) on B cells from human fetal tissues. A multiple phenotypic characterization.
1985-01-01 D., Delia; G., Cattoretti; Bonati, Antonio; S., Villa; F., De Braud; M., Buscaglia
Discordant expression of terminal transferase and T cell receptor beta chain in fetal and pediatric thymocytes.
1989-01-01 Bonati, Antonio; G., Cattoretti; R., Starcich
Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts
2003-01-01 Lunghi, Paolo; Tabilio, A; Dall'Aglio, Pier Paolo; Ridolo, Erminia; Carlostella, C; Pelicci, Pg; Bonati, Antonio
Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis
2004-01-01 Giuliani, Nicola; Lunghi, Paolo; Morandi, F; Colla, Simona; Bonomini, S; Hojden, M; Rizzoli, Vittorio; Bonati, Antonio
Early proinflammatory activation of renal tubular cells by normal and pathologic IgG
2005-01-01 Ronda, Nicoletta; Cravedi, P.; Benozzi, L.; Lunghi, P.; Bonati, Antonio; Allegri, Landino; Carnevali, M. L.; Caserta, C.; Borghetti, A.; Buzio, Carlo
Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells.
1996-01-01 C., Carlo Stella; E., Regazzi; D., Garau; L., Mangoni; M. T., Rizzo; Bonati, Antonio; G., Dotti; C., Almici; V., Rizzoli
Elevated telomerase activity, minimal telomere loss in cord blood long-term cultures with extensive stem cell replication
2004-01-01 Gammaitoni, L; Weisel, Kc; Gunetti, M; Wu, Kd; Bruno, S; Pinelli, Silvana; Bonati, Antonio; Aglietta, M; Moore, Mas; Piacibello, W.
Emerging MEK inhibitors
2010-01-01 Mccubrey, J. A.; Steelman, L. S.; Abrams, S. L.; Chappell, W. H.; S., Russo; R., Ove; M., Milella; A., Tafuri; Lunghi, Paolo; Bonati, Antonio; F., Stivala; F., Nicolettti; M., Libra; Martelli, A. M.; G., Montalto; M., Cervello
Emerging Raf inhibitors
2009-01-01 Mccubrey, Ja; Steelman, Ls; Abrams, Sl; Chappell, Wh; Russo, S; Ove, R; Milella, M; Tafuri, A; Lunghi, P; Bonati, Antonio; Stivala, F; Nicoletti, F; Libra, M; Martelli, Am; Montalto, G; Cervello, M.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A micro-mechanically motivated model for the strength of heat-treated glass | 1-gen-2018 | Bonati, Antonio; Occhiuzzi, Antonio; Pisano, Gabriele; Royer-Carfagni, Gianni | |
Acenaphthenequinone thiosemicarbazone and its transition metal complexes: synthesis, structure, and biological activity. | 1-gen-1997 | M. C., Rodriguez Argüelles; M., Belicchi Ferrari; G., Gasparri Fava; C., Pelizzi; Pelosi, Giorgio; Albertini, Roberto; Bonati, Antonio; P. P., Dall'Aglio; Lunghi, Paolo; S., Pinelli | |
Arsenic Trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells | 1-gen-2005 | Lunghi, P.; Tabilio, A.; LO COCO, F.; Pelicci, P. G.; Bonati, Antonio | |
Arsenic Trioxide in hematological malignancies: the new discovery of an ancient drug. | 1-gen-2006 | Bonati, Antonio; Rizzoli, V; Lunghi, P. | |
Aurora and IKK kinases cooperatively interact to protect multiple myeloma cells from Apo2L/TRAIL | 1-gen-2013 | Mazzera, L; Lombardi, G; Abeltino, M; Ricca, M; Donofrio, Gaetano; Giuliani, Nicola; Cantoni, Anna Maria; Corradi, Attilio; Bonati, Antonio; Lunghi, Paolo | |
BCL2 oncogene protein expression in human hematopoietic precursors during fetal life. | 1-gen-1996 | Bonati, Antonio; Albertini, Roberto; D., Garau; Pinelli, Silvana; Lunghi, Paolo; C., Almici; C., Carlo Stella; Rizzoli, Vittorio; P., Dall'Aglio | |
Biochemical, Immunological, and Molecular Markers of Hemopoietic Precursor Cells. | 1-gen-1991 | Bonati, Antonio | |
Calibration of the Statistical-Interference Factors for the Design of Tempered Structural Glass | 1-gen-2022 | Pisano, Gabriele; Bonati, Antonio; ROYER CARFAGNI, Gianni | |
Combined treatment with the MEK inhibitor PD0325901 and Arsenic Trioxide has potent anti-tumor activity in vivo against human multiple myeloma xenograft model. | 1-gen-2008 | Lunghi, P; Mazzera, L; Lombardi, G; Ricca, M; Corradi, Attilio; Cantoni, Anna Maria; Giuliani, Nicola; Salvatore, L; Riccioni, R; Costanzo, A; Testa, U; Levrero, M; Rizzoli, Vittorio; Bonati, Antonio | |
Combined treatment with the MEK inhibitor PD0325901 and Arsenic Trioxide has potent antitumor activity in NOD-SCID mice bearing advanced tumors of human multiple myeloma. | 1-gen-2009 | Lunghi, P; Mazzera, L; Lombardi, G; Ricca, M; Corradi, Attilio; Cantoni, Anna Maria; Giuliani, Nicola; Salvatore, L; Riccioni, R; Costanzo, A; Testa, U; Levrero, M; Rizzoli, V; Bonati, Antonio | |
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia | 1-gen-2008 | Steelman, Ls; Abrams, Sl; Whelan, J; Bertrand, Fe; Ludwig, De; Bäsecke, J; Libra, M; Stivala, F; Milella, M; Tafuri, A; Lunghi, P; Bonati, Antonio; Martelli, Am; Mccubrey, Ja | |
Detection of the common acute lymphoblastic leukaemia antigen (CALLA) on B cells from human fetal tissues. A multiple phenotypic characterization. | 1-gen-1985 | D., Delia; G., Cattoretti; Bonati, Antonio; S., Villa; F., De Braud; M., Buscaglia | |
Discordant expression of terminal transferase and T cell receptor beta chain in fetal and pediatric thymocytes. | 1-gen-1989 | Bonati, Antonio; G., Cattoretti; R., Starcich | |
Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts | 1-gen-2003 | Lunghi, Paolo; Tabilio, A; Dall'Aglio, Pier Paolo; Ridolo, Erminia; Carlostella, C; Pelicci, Pg; Bonati, Antonio | |
Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis | 1-gen-2004 | Giuliani, Nicola; Lunghi, Paolo; Morandi, F; Colla, Simona; Bonomini, S; Hojden, M; Rizzoli, Vittorio; Bonati, Antonio | |
Early proinflammatory activation of renal tubular cells by normal and pathologic IgG | 1-gen-2005 | Ronda, Nicoletta; Cravedi, P.; Benozzi, L.; Lunghi, P.; Bonati, Antonio; Allegri, Landino; Carnevali, M. L.; Caserta, C.; Borghetti, A.; Buzio, Carlo | |
Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells. | 1-gen-1996 | C., Carlo Stella; E., Regazzi; D., Garau; L., Mangoni; M. T., Rizzo; Bonati, Antonio; G., Dotti; C., Almici; V., Rizzoli | |
Elevated telomerase activity, minimal telomere loss in cord blood long-term cultures with extensive stem cell replication | 1-gen-2004 | Gammaitoni, L; Weisel, Kc; Gunetti, M; Wu, Kd; Bruno, S; Pinelli, Silvana; Bonati, Antonio; Aglietta, M; Moore, Mas; Piacibello, W. | |
Emerging MEK inhibitors | 1-gen-2010 | Mccubrey, J. A.; Steelman, L. S.; Abrams, S. L.; Chappell, W. H.; S., Russo; R., Ove; M., Milella; A., Tafuri; Lunghi, Paolo; Bonati, Antonio; F., Stivala; F., Nicolettti; M., Libra; Martelli, A. M.; G., Montalto; M., Cervello | |
Emerging Raf inhibitors | 1-gen-2009 | Mccubrey, Ja; Steelman, Ls; Abrams, Sl; Chappell, Wh; Russo, S; Ove, R; Milella, M; Tafuri, A; Lunghi, P; Bonati, Antonio; Stivala, F; Nicoletti, F; Libra, M; Martelli, Am; Montalto, G; Cervello, M. |